Pathogenetic insight in idiopathic orbital inflammatio

Withdrawn

• Conditions: idiopathic orbital inflammation; orbital inflammation of unknown etiology; 10015917

• Registration Number: NL-OMON30470
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

Adult patients presenting to the ophthalmology clinic with signs of (sub) acute infiltration and inflammation of intraorbital structures together with symptoms of eyelidedema, conjunctival injection, chemosis, pain and/or motilitydisturbances.

Exclusion Criteria

Exclusion of identifiable local causes such as neoplasia, primary infection and systemic diseases like Wegener and Graves'.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Prospective case-control study: infectious study: presence/absence of twenty<br /><br>virusses and micro-organisms; genomic study: differential expression of<br /><br>twenty-five proteins involved in inflammation and tissue (re)-generation.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>none</p><br>